Daniel Brennan
Overview
Daniel Brennan received an average of $3M in total compensation, including $137K in salary, at INSYS Therapeutics between 2015 and 2016.
Source: SEC filing on April 17, 2017.
Related executives
We found seven more executives who work or worked at INSYS Therapeutics.
Saeed Motahari
INSYS Therapeutics
Chief Executive Officer
Franc Del Fosse
INSYS Therapeutics
General Counsel
Andrew Long
INSYS Therapeutics
Chief Financial Officer
Darryl Baker
INSYS Therapeutics
Chief Financial Officer
Santosh Vetticaden
INSYS Therapeutics
Chief Executive Officer
John Kapoor
INSYS Therapeutics
Chief Executive Officer
Michael Babich
INSYS Therapeutics